# Pennant Group, Inc. (PNTG)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/pennant-group-inc/ JSON: https://steadybase.io/company/pennant-group-inc.json Checked Nov 10, 2026. Latest filing read: Nov 4, 2026.

## Company

- Legal name: Pennant Group, Inc.
- Ticker: PNTG (Nasdaq)
- SEC CIK: 0001766400
- Industry: Services-Health Services (SIC 8000)
- Headquarters: Eagle, ID
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: pennantgroup.com
- LinkedIn: https://www.linkedin.com/company/thepennantgroup
- Next earnings date: Feb 3, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $947.7M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/0001766400-26-000014-index.html
- Operating income: $51.9M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/0001766400-26-000014-index.html
- Net income: $29.6M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/0001766400-26-000014-index.html
- SG&A: $71.1M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 26, 2026). Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/0001766400-26-000014-index.html
- Employees: 9,700 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- Shares outstanding: 35,132,364 as of Nov 2, 2026 (10-Q filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000071/0001766400-26-000071-index.html
- Auditor: Deloitte & Touche LLP, Boise, ID, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm

## Business

The Pennant Group, Inc. is a leading provider of high-quality healthcare services to patients, residents, and clients of all ages, including the growing senior population, in the United States. We strive to be the provider of choice in the communities we serve through our innovative operating model and unique core values.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $947.7M | $51.9M | $29.6M | $71.1M |
| Dec 31, 2024 | $695.2M | $38.1M | $22.6M | $50.2M |
| Dec 31, 2023 | $544.9M | $25.2M | $13.4M | $36.7M |
| Dec 31, 2022 | $473.2M | $12.7M | $6.6M | $34.0M |
| Dec 31, 2021 | $439.7M | $4.7M | $2.7M | $36.3M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/pennant-group-inc.json

## Officers and directors

- Brent Guerisoli, The Company’s Chief Executive Officer. Source: 8-K filed Nov 4, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000069/q32026earningspressrelease.htm
- Lynette Walbom, Chief Financial Officer. Source: 4/A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000039/0001766400-26-000039-index.htm
- Lynette B. Walbom, Chief Financial Officer. LinkedIn: https://linkedin.com/in/lynette-walbom-10a6407. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- John Gochnour, The Company’s Chief Operating Officer. Source: 8-K filed Nov 4, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000069/q32026earningspressrelease.htm
- John J. Gochnour, Chief Operating Officer. LinkedIn: https://linkedin.com/in/john-gochnour-161a2223. Source: 4/A filed Apr 17, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000046/0001766400-26-000046-index.htm
- Jason Paul Steik, Chief Clinical Officer. Source: Form 4 filed Aug 10, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000207837426000003/0002078374-26-000003-index.htm
- Kirk Sterling Cheney, EVP, GC and Corp Secy. Source: Form 4 filed Aug 10, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000067/0001766400-26-000067-index.htm
- Barry M. Smith, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- Christopher R. Christensen, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- Gregory K. Morris M.D., Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- John G. Nackel, Ph.D., Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- Scott E. Lamb, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- Stephen M. R. Covey, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- Suzanne D. Snapper, Director. Source: 10-K filed Feb 26, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- Jason P. Steik, Named in proxy. Source: DEF 14A filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000027/pntg-20260331.htm
- Kirk S. Cheney, Named in proxy. Source: DEF 14A filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000027/pntg-20260331.htm

## Recent 8-K events

- Nov 4, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000069/pntg-20261104.htm
- Aug 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000064/pntg-20260805.htm
- May 20, 2026: Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000056/pntg-20260520.htm
- May 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000053/pntg-20260506.htm
- Feb 25, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000011/pntg-20260225.htm
- Nov 5, 2025: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640025000141/pntg-20251105.htm
- Nov 5, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640025000137/pntg-20251105.htm
- Oct 2, 2025: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640025000114/pntg-20251002.htm
- Oct 2, 2025: Item 2.01, Completion of acquisition or disposition of assets; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640025000113/pntg-20251002.htm
- Aug 6, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640025000102/pntg-20250806.htm

## Insider trades (Form 4)

- Aug 6, 2026: Jason Paul Steik (Chief Clinical Officer) sold 1,394 shares, about $53,697. Source: https://www.sec.gov/Archives/edgar/data/1766400/000207837426000003/0002078374-26-000003-index.htm
- Aug 6, 2026: Brent Guerisoli (Chief Executive Officer) sold 4,285 shares, about $165,058. Source: https://www.sec.gov/Archives/edgar/data/1766400/000183836026000007/0001838360-26-000007-index.htm
- Aug 6, 2026: Kirk Sterling Cheney (EVP, GC and Corp Secy) sold 1,393 shares, about $53,658. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000067/0001766400-26-000067-index.htm
- Jul 10, 2026: Brent Guerisoli (Chief Executive Officer) sold 3,159 shares, about $131,320. Source: https://www.sec.gov/Archives/edgar/data/1766400/000183836026000005/0001838360-26-000005-index.htm
- Jul 7, 2026: Brent Guerisoli (Chief Executive Officer) sold 3,165 shares, about $128,214. Source: https://www.sec.gov/Archives/edgar/data/1766400/000183836026000003/0001838360-26-000003-index.htm
- May 22, 2026: Brent Guerisoli (Chief Executive Officer) sold 4,508 shares, about $158,140. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000061/0001766400-26-000061-index.htm
- Jul 28, 2025: Kirk Sterling Cheney (EVP, GC and Corp Secy) sold 880 shares, about $20,539. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640025000106/0001766400-25-000106-index.htm
- Jul 28, 2025: Brent Guerisoli (Chief Executive Officer) sold 3,995 shares, about $93,243. Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640025000096/0001766400-25-000096-index.htm

## What management said

- "Pennant delivered a solid quarter and strong year-over-year improvement across the organization" Brent Guerisoli, the Company’s Chief Executive Officer (8-K filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000069/q32026earningspressrelease.htm
- "Over the last two years, we have added 75 home health and hospice locations and 16 senior living communities to our organization" John Gochnour, the Company’s Chief Operating Officer (8-K filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000069/q32026earningspressrelease.htm

## Latest filings

- 8-K filed Aug 5, 2026: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000064/pntg-20260805.htm
- 10-K filed Feb 26, 2026: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/pntg-20251231.htm
- 10-Q filed Aug 5, 2026: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000065/pntg-20260630.htm
- DEF 14A filed Mar 31, 2026: https://www.sec.gov/Archives/edgar/data/1766400/000176640026000027/pntg-20260331.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/